E. Schwartz

Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation

Laura G. Dubois, M. A. Moseley, J. Thompson, 2013, Clinical Proteomics.

MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease

G. Palmer, R. Zennadi, E. Schwartz, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Structural basis for assembly of non-canonical small subunits into type I-C Cascade

David W. Taylor, D. Wrapp, J. Brodbelt, 2020, Nature Communications.

Structural rearrangements allow nucleic acid discrimination by type I-D Cascade

David W. Taylor, D. Wrapp, E. Schwartz, 2022, Nature Communications.

MEK 1 / 2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease

G. Palmer, R. Zennadi, E. Schwartz, 2015 .

Assembly of multi-subunit fusion proteins into the RNA-targeting type III-D CRISPR-Cas effector complex

Caitlyn L. McCafferty, J. Brodbelt, E. Schwartz, 2022, bioRxiv.

Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation

Laura G. Dubois, M. A. Moseley, J. Thompson, 2013, Clinical Proteomics.

Diverse CRISPR-Cas Complexes Require Independent Translation of Small and Large Subunits from a Single Gene.

David W. Taylor, E. Schwartz, P. C. Fineran, 2020, Molecular cell.

Diverse CRISPR-Cas complexes require independent translation of small and large subunits from a single gene

David W. Taylor, E. Schwartz, P. C. Fineran, 2020, bioRxiv.

Diverse CRISPR-Cas complexes require independent translation of small and large subunits from a single gene

David W. Taylor, E. Schwartz, P. C. Fineran, 2020, bioRxiv.

Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage

David W. Taylor, Caitlyn L. McCafferty, J. Brodbelt, 2023, Research Square.